You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bi-Specific

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Disease Trial in Shenzhen (bi-4SCAR PSMA/CD70 T cells)

Recruiting
  • Cancer Disease
  • bi-4SCAR PSMA/CD70 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

Cancer Disease Trial in Shenzhen (bi-4SCAR GD2/CD70 T cells)

Recruiting
  • Cancer Disease
  • bi-4SCAR GD2/CD70 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

Malignant Disease Trial in Shenzhen (bi-4SCAR GD2/CD56 T cells)

Recruiting
  • Malignant Disease
  • bi-4SCAR GD2/CD56 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

B Cell Malignancies Trial in Shenzhen (bi-4SCAR CD19/70 T cells)

Recruiting
  • B Cell Malignancies
  • bi-4SCAR CD19/70 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 28, 2022

B Cell Malignancies Trial in Shenzhen (bi-4SCAR CD19/22 T cells)

Recruiting
  • B Cell Malignancies
  • bi-4SCAR CD19/22 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 21, 2022

B Cell Malignancies Trial in Shenzhen (bi-4SCAR CD19/79b T cells)

Recruiting
  • B Cell Malignancies
  • bi-4SCAR CD19/79b T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 28, 2022

Solid Tumor Trial in Shenzhen (bi-4SCAR GD2/PSMA T cells)

Recruiting
  • Solid Tumor
  • bi-4SCAR GD2/PSMA T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Cancer
  • Bengbu, Anhui, China
  • +12 more
Dec 13, 2022

New BI-specifiC Antibody Towards Dendritic Cells on Inflammation

Completed
  • Rheumatoid Arthritis
  • +2 more
  • Puncture
  • Tours, France
    Rheumatology Department, University Hospital, Tours
Dec 22, 2021

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Aug 10, 2022

Gynecologic Cancer, Cancer Metastatic, Ovarian Tumors Trial in Qilu, Chongqing (AK112)

Active, not recruiting
  • Gynecologic Cancer
  • +4 more
  • Qilu, Shandong, China
  • +1 more
Oct 8, 2022

Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Frankston, Victoria, Australia
  • +2 more
Nov 3, 2022

Glioma, Brain Metastases Trial in Shanghai (Autologous progenitor expansion -T, pemetrexed)

Recruiting
  • Glioma
  • Brain Metastases
  • Shanghai, Shanghai, China
    Fudan University Pudong Medical Center
Jul 12, 2022

Maxillary Repositioning With bi or Tripartite Disjonction by

Completed
  • Occlusal Trauma
  • bimaxillair osteotomy with maxillar segmentation
  • Nice, France
    Nice University Hospital - IUFC
Jan 12, 2022

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Healthy Subjects Trial in Baltimore (MGD010, Placebo, Hepatitis A vaccine)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Feb 4, 2022

HIV Trial in Sacramento, San Francisco (drug, biological, other)

Recruiting
  • HIV Infections
  • Sacramento, California
  • +1 more
May 17, 2022

Advanced Solid Tumors Trial in Australia, China, United States (EMB-02)

Recruiting
  • Advanced Solid Tumors
  • EMB-02
  • Colorado Springs, Colorado
  • +5 more
Mar 28, 2022

Metastatic Colorectal Cancer Trial in Washington (TF2/IMP288)

Withdrawn
  • Metastatic Colorectal Cancer
  • Washington, District of Columbia
    Georgetown University Medical Center
Aug 12, 2021

Psychotic Disorders Trial in Worldwide (BI 409306, Placebo)

Terminated
  • Psychotic Disorders
  • BI 409306
  • Placebo
  • Culver City, California
  • +32 more
Sep 30, 2021

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

Advanced Solid Tumor Trial in Beijing (IBI315)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
    The 307th Hospital of Chinese People's Liberation Army
Nov 27, 2019

Bi-rads Class 4 Breast Lesions

Completed
  • Breast Disease
  • no intervention
  • Shandong, China
    QianfoshanH
Aug 30, 2023